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COMMENTS {#sec2}
========

The authors present a unique case of surgical middle cerebral artery thrombectomy following initially successful tissue plasminogen activator administration and resolution of symptoms. While the case presented is rare, it is an excellent example of the benefits that can be realized when medical, surgical, and endovascular therapies are considered and appropriately applied in integrated stroke system of care. The viewer should be directed to the discussion of fibrinogen level evaluation to determine surgical bleeding risk. The authors summarize this well. The only critique that I can find is the establishment of proximal and distal control during the initial arteriotomy. It should be expected that any patient with those CTA findings and a fluctuating exam over 8 hours would have produce moderate retrograde flow. The possibility of distal emboli during the plaque manipulation should also affect the decision to place at least 1 distal clip. This was a fun case to watch.

**Babu G. Welch**

*Dallas, Texas*

 {#sec3}

The authors should be commended on their excellent operative video. In the age of endovascular therapy, the new stentrievers and thromboaspiration devices should be given atrial prior to initiating open surgical treatment. Regardless, the authors apply perfusion data to select an appropriate that was not responding to tPA therapy. Other than attempting to elevate her blood pressure or endovascular therapy, the authors appropriately performed an open embolectomy of a calcified thrombus in the M2. The operative technique and video is educational and worth having as a third-tier option in stroke therapy.

**Daniel Felbaum**

**Erol Veznedaroglu**

*Philadelphia, Pennsylvania*
